drugset / Trial / NCT00420004
A Study for Participants With Major Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study to assess the safety and effectiveness of LY2216684 compared to placebo in treating adults with major depressive disorder.
Timeline
- Start
- 2006-12
- Primary completion
- 2008-03
- Completion
- 2008-03
Outcome
Missed primary endpoint
registry analysis (superiority or other test); LY2216684 vs Placebo; p = 0.494; Mixed Models Analysis NCT00420004 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Escitalopram | Small molecule | 10 mg | Oral |
| Comparator | Escitalopram | Small molecule | 20 mg | Oral |
| Subject | edivoxetine | Small molecule | 3 mg | Oral |
| Subject | edivoxetine | Small molecule | 6 mg | Oral |
| Subject | edivoxetine | Small molecule | 9 mg | Oral |
| Subject | edivoxetine | Small molecule | 12 mg | Oral |